Yee Ying Leung
Directeur Général chez Antiviral Technologies, Inc.
Profil
Yee Ying Leung is the founder of Walcom Group Ltd.
Currently, Ms. Leung is the Chief Executive Officer & Director at Antiviral Technologies, Inc. Ms. Leung completed an undergraduate degree from the University of Toronto in 1985.
Postes actifs de Yee Ying Leung
| Sociétés | Poste | Début |
|---|---|---|
Antiviral Technologies, Inc.
 Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Directeur Général | 28/03/2014 |
Anciens postes connus de Yee Ying Leung
| Sociétés | Poste | Fin |
|---|---|---|
| WALCOM GROUP LIMITED | Fondateur | - |
Formation de Yee Ying Leung
| University of Toronto | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Antiviral Technologies, Inc.
Antiviral Technologies, Inc. Financial ConglomeratesFinance Antiviral Technologies, Inc. operates as a development stage biotechnology company utilizing cysteamine compositions in the development of antiviral drugs for human application. It operates business through subsidiary Obio Pharmaceutical (HK) Ltd. The company has offices in Beijing and Hong Kong. Antiviral Technologies was founded on September 13, 2007 and is headquartered in Hong Kong. | Finance |
Walcom Group Ltd.
 Walcom Group Ltd. Pharmaceuticals: GenericHealth Technology Walcom Group Ltd. is a holding company, which engages in the research, development, commercialization, production and marketing of animal feed additive products. Its products include Porcinin Plus, Porcimax, Eggronin Plus, and Aquanin Plus. It operates through the following geographical segments: Hong Kong, China, Philippines, Thailand, Taiwan, Other Asia-Pacific Countries, Europe and the United Kingdom, America and Canada, and Others. The company was founded in 2004 and is headquartered in Shanghai, China. | Health Technology |
